A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids by Read, Martin L. et al.
A versatile reducible polycation-based system for
efficient delivery of a broad range of nucleic acids
Martin L. Read*, Surjeet Singh
1, Zubair Ahmed, Mark Stevenson
2, Simon S. Briggs
2,
David Oupicky
3, Lee B. Barrett
4, Rachel Spice, Mark Kendall
5, Martin Berry,
Jon A. Preece
1, Ann Logan and Leonard W. Seymour
2
Molecular Neuroscience Group, Department of Medicine, University of Birmingham, Birmingham, B15 2TT, UK,
1School of Chemistry, University of Birmingham, B15 2TT, UK,
2Department of Clinical Pharmacology,
University of Oxford, Oxford, OX2 6HE, UK,
3Department of Pharmaceutical Sciences, Wayne State University,
Detroit, MI 48202, USA,
4Department of Anesthesia and Critical Care, Massachusetts General Hospital
and Harvard Medical School, Boston, MA 02129, USA and
5Department of Engineering Science,
University of Oxford, Oxford, OX1 3PJ, UK
Received December 17, 2004; Revised February 10, 2005; Accepted May 9, 2005
ABSTRACT
Synthetic vectors based on reducible polycations
consisting of histidine and polylysine residues (HIS
RPCs) were evaluated for their ability to deliver nuc-
leicacids.InitialexperimentsshowedthatRPC-based
vectors with at least 70% histidine content mediated
efficient levels of gene transfer without requirement
for the endosomolytic agent chloroquine. Significant
gene transfer was observed in a range of cell types
achieving up to a 5-fold increase in the percentage
of transfected cells compared to 25 kDa PEI, a gold
standard synthetic vector. In contrast to 25 kDa PEI,
HIS RPCs also mediated efficient transfer of other
nucleic acids, including mRNA encoding green
fluorescent protein in PC-3 cells and siRNA directed
against the neurotrophin receptor p75
NTR in post-
mitotic cultures of rat dorsal root ganglion cell neur-
ons. Experiments to elevate intracellular glutathione
and linear profiling of cell images captured by multi-
photon fluorescent microscopy highlighted that
parameters such as the molecular weight and rate of
cleavageofHISRPCswereimportantfactorsindeter-
mining transfection activity.Altogether,theseresults
demonstrate that HIS RPCs represent a novel and
versatile type of vector that can be used for efficient
cytoplasmic delivery of a broad range of nucleic
acids. This should enable different or a combination
of therapeutic strategies to be evaluated using a
single type of polycation-based vector.
INTRODUCTION
There has been rapid progress in the development of different
types of nucleic acids including protein-encoding genes, oli-
gonucleotides and mRNA with the potential to form the basis
of new treatments for genetic and acquired disorders in
humans. In particular, the recent emergence of small interfer-
ing RNA (siRNA) to trigger RNA interference has initiated
efforts to identify siRNA sequences capable of modulating the
function of a vast number of genes (1). However, a major
hurdle to the continued development and therapeutic applica-
tion of nucleic acids is the lack of suitable vectors for their
delivery. There are several issues that need to be addressed
before efﬁcient delivery vectors can be developed; including
the toxicity of vectors observed in clinical studies (2,3) and the
lack of targeting of vectors to speciﬁc cell types. In addition, it
would be advantageous to design vectors that are capable of
delivering a broad range of nucleic acids to evaluate different
or a combination of therapeutic strategies.
Synthetic vectors based on polycations such as polyethyl-
enimine (PEI) (4) or poly-L-lysine (PLL) (5,6) have been
widely used to transfer nucleic acids to cells. The beneﬁts
of using synthetic vectors are their ability to complex and
deliver large quantities of nucleic acids of virtually any size
and they are also generally regarded as being safer than viral
vectors. However, the transfection efﬁciency of synthetic vec-
tors is typically poor compared to viral vectors and signiﬁcant
improvements are required to enable further clinical develop-
ment. Several barriers that limit nucleic acid transfer both
in vitro and in vivo have been identiﬁed, and include poor
intracellular delivery (7), toxicity (8) and instability of vectors
in physiological conditions (9). PLL, for example, binds elec-
trostatically to the phosphate groups of DNA forming discrete
*To whom correspondence should be addressed. Tel: +44 121 627 2331; Fax: +44 121 472 0499; Email: mread@globalnet.co.uk
  The Author 2005. Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access
version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press
areattributedastheoriginalplaceofpublicationwiththecorrectcitationdetailsgiven;ifanarticleissubsequentlyreproducedordisseminatednotinitsentiretybut
only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oupjournals.org
Nucleic Acids Research, 2005, Vol. 33, No. 9 e86
doi:10.1093/nar/gni085polyplexes with diameters in the range of 50–100 nm.
However, PLL is incapable of mediating efﬁcient escape
from endocytic vesicles into the cytoplasm, and poor gene
expression is observed in vitro without the use of endosomo-
lytic agents such as chloroquine (10).
The transfection properties of polyplexes can be inﬂuenced
by the type and molecular weight (mwt) of polycation used.
We have previously demonstrated, for example, that plasmid
DNA complexed with 211 kDa PLL was more stable to salt-
induced aggregation than 20 kDa PLL and gave a 20-fold
greater level of DNA in the plasma of mice 30 min after
intravenous administration (11). However, there are several
disadvantages in using higher mwt polycations for gene trans-
fer including their reported ability to hinder unpacking of
DNA from polyplexes (7) and toxicity. Intravenous injection
of 211 kDa PLL/DNA polyplexes to Wistar rats, for example,
resulted in hematuria that may have been mediated by direct
erythrocyte lysis (11).
A strategy to reduce the toxicity of polyplexes but retain
their stability in physiological conditions is to cross-link low
mwt polycations bound to DNA such that cleavage by the
intracellular environment facilitates the release of DNA
(12). Recently, we developed a synthetic vector based on a
linear reducible polycation (RPC) prepared by oxidative poly-
condensation of the peptide Cys-Lys10-Cys (13). Cleavage
of RPC by the intracellular reducing environment decreased
toxicity of the polycation to levels comparable with low mwt
peptides.Inaddition,efﬁcientintracellularreleaseofDNAand
gene transfer was shown in a range of cell types using vectors
based on RPC. A related approach has also been used by McK-
enzie et al. where low mwt peptides containing two to ﬁve
cysteine groups, such as Cys-Trp-Lys8-Cys-Lys8-Cys, were
mixed with DNA prior to spontaneous oxidation to form inter-
peptide disulﬁde bonds (14). However, a major drawback in
both of these studies was that chloroquine (13,14) or cationic
lipids (13) were required to facilitate endocytic escape of poly-
plexes and mediate efﬁcient levels of gene transfer.
In the present study, we investigated whether efﬁcient gene
therapy vectors based on RPCs could be developed by the
inclusion of histidine residues that have a known endosomal
buffering capacity. We show that histidine-rich RPCs can be
cleaved by the intracellular reducing environment enabling
efﬁcient cytoplasmic delivery of a broad range of nucleic
acids, including plasmid DNA, mRNA and siRNA molecules
without the requirement for the endosomolytic agent chloro-
quine. Furthermore, we demonstrate efﬁcient delivery of nuc-
leic acids in both rapidly dividing cells and in primary cultures
of post-mitotic cells. These histidine-rich RPCs can be readily
modiﬁed by the incorporation of targeting ligands and hydro-
philic polymers to improve their utility and biocompatibility.
Hence, these ﬁndings should help to facilitate the design and
construction of efﬁcient and versatile synthetic delivery vec-
tors capable of evaluating therapeutic strategies with different
or combinations of nucleic acids.
MATERIALS AND METHODS
Cell lines and primary cells
The human prostatic cell lines PC-3 and DU145, ovarian
carcinoma cell line SKOV-3, liver carcinoma cell lines
HepG2 and Alexander, breast carcinoma cell line MCF7,
lung carcinoma cell line A549 and green monkey transformed
cell line COS-7 were grown in DMEM containing 1 mM
Glutamax, glucose (1g/l, Invitrogen) and 10% foetal calf
serum (FCS). The human prostate cell lines LNCaP, PNT1a
(15) and PNT2 (16,17) were grown in RPMI 1640 medium
with 2 mM glutamine and 10% FCS. All cell lines were incub-
ated at 37 C in a 5% CO2 humidiﬁed environment. Dorsal root
ganglion (DRG) cultures were prepared from adult Sprague–
Dawley rats. Brieﬂy, spinal ganglia were removed aseptically,
washed twice in Neurobasal-A media (Invitrogen) and diges-
ted in 0.125% collagenase/supplemented Neurobasal-A (2%
B27 supplement, 0.5 mM L-glutamine and 0.5% gentimicin)
for 2 h at 37 C. Spinal ganglia were removed from the col-
lagenase, washed in Neurobasal-A and puriﬁed by centrifuga-
tion for 10 min at 120 g on a 15% bovine serum albumin
column.
Sources of nucleic acids and polycations
The reporter gene expression plasmids pEGFPN1 (Clontech,
Oxford, UK) and pCMVLuc1 (a gift from Dr Manfred Ogris,
Munich, Germany) were used throughout these studies.
Plasmid DNA was grown in Escherichia coli and puriﬁed
using Qiagen Gigaprep kits (Crawley, West Sussex, UK).
The concentration and purity of DNA was checked on a spec-
trophotometer at A260 and A280 absorbance wavelengths.
mRNA encoding green ﬂuorescent protein (GFP) was pre-
pared by in vitro transcription of the plasmid pGEM4Z/
GFP/A64 (a gift from Dr D. Boczkowski, Duke University
Medical Center, NC) using the mMessagemMachine kit and
cappedwiththeanti-reversecapanalog(ARCA)fromAmbion
(Huntingdon, Cambridgeshire, UK). Construction of this plas-
mid is described elsewhere (18). Products were checked by
gel electrophoresis and were  900 bases in length. To design
target-speciﬁc siRNA duplexes, we selected siRNA sequences
directed against p75
NTR using criteria set out by Elbashir et al.
(19) from the open reading frame of rat p75
NTR mRNA, NCBI
accession number NM012610. The siRNA sequences used
were Seq2, 50-AACGCTTGATGCCCTTTTAGC-30; and Scr2,
50-AATCGCATGCGTTCCATTTCG-30. Oligonucleotide tem-
plates and control scrambled sequences were chemically syn-
thesized (Alta Biosciences, University of Birmingham, UK)
and siRNA sequences constructed using the Silencer siRNA
Construction kit (Ambion, TX, USA). GFP-22 siRNA was
purchased from Qiagen, Crawley, UK. The cationic polymers
used were branched polyethylenimine (PEI, 25 kDa; Aldrich),
linear PEI (4xJetPEI; Qbiogene, Wiesbaden, Germany) and
poly(L-lysine). HBr (PLL, 54 and 84 kDa; Sigma).
Peptide synthesis and purification
The CH3K3H3C (HIS3 monomer), CH6K3H6C (HIS6
monomer) and CK10C peptides were synthesized using a
Biosystems automated peptide synthesizer and standard
Fmoc protocols. Cleavage from the polymeric support and
deprotection of amino acid side chainresidues were performed
in 10 ml of triﬂuoroacetic acid/water/phenol/triisopropylsilane
(88:5:5:2 v/v) for 2–4 h at room temperature. The soluble
product was then concentrated in vacuo and precipitated by
washing with cold diethyl ether. The peptides were then dis-
solved in distilled water and lyophilized to yield a white solid.
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reversed-phase HPLC on a C18 column. Once the peptides had
been eluted, elution solvent was removed in vacuo followed
by lyophilization. The peptides were then characterized by
MALDI-TOF mass spectrometry and NMR. The purity of
all peptides was shown to be >95% by analytical reversed-
phase HPLC.
Preparation and characterization of RPCs
Polycondensation reactions were performed with 10 mg of
each peptide in phosphate-buffered saline (PBS) containing
30 vol% DMSO and allowed to react at room temperature for
4 days as previously described (20). At certain time intervals
during the step growth polymerization, an aliquot of the
reaction mixture was removed and terminated with 8 mol%
excess of 2-aminoethanethiol. The mwts (weight averages)
of resulting RPCs at various time points were measured by
gel permeation chromatography (GPC) using calibration
with commercially available PLL with mwts in the range
13.4–84 kDa. The standards and RPCs (10 ml) were injected
on a CATSEC 300 GPC column and eluted in 300 mM
NaCl + 0.1% TFA. RPCs were puriﬁed from DMSO and
cyclic by-products using centrifugal ultra ﬁlters with mwt
cut-off 10000. The concentrations of RPCs were determined
by 2,4,6-trinitrobenzenesulfonic acid (TNBS) using PLL cal-
ibration. The
1H NMR titration for the determination of pKa
values of histidine moieties was performed at 300K using
10 mg of each peptide in deuterated water in a Brucker AC
300 MHz spectrometer. The chemical shifts of the H5 and H6
protons of the imidazole ring of the histidine residues were
measured asa function of pH.The pKavalues were determined
by plotting the chemical shift against pH. The pH of the
solution was adjusted by addition of 100 mM deuterated
sodium hydroxide.
Formation and characterization of polyplexes
Plasmid DNA, mRNA or siRNA were added to a polypropyl-
ene microcentrifuge tube at a ﬁnal concentration of 50 mg/ml
in ultra-pure water or 20 mM HEPES–NaOH, pH 7.4 as indic-
ated. Polycation was added to the nucleic acid at the desired
(w/w) ratio or N:P ratio and mixed by gently pipetting the
solution up and down several times. Polyplexes were then
allowed to form for at least 15 min at room temperature
prior to use. In some cases, HIS RPC/DNA polyplexes
were incubated in 150 mM NaCl for 30 min prior to addition
to cells. In co-transfection experiments, pEGFPN1 and GFP-
22 siRNA were condensed either by HIS6 RPC in water at
(w/w) ratio of 24 or 4xJetPEI in 150 mM NaCl at N:P ratio
of 5–10 and incubated for 30 min at room temperature prior
to use.
The weight per charge of the CH3K3H3C and CH6K3H6C
peptides were 257.2 and 254.9, respectively. Formation of HIS
RPC/DNA polyplexes at (w/w) ratio of 40, for example, was
equivalent to an N:P ratio of  32. Condensation of plasmid
DNA by polycations was determined using an ethidium brom-
ide (EtBr) exclusion assay measured with an LS-50B ﬂuori-
meter (Perkin-Elmer, Bucks, UK) at 510 nm excitation and
590 nm emission wavelengths and by the agarose gel retarda-
tion assay as previously described (21). The hydrodynamic
diameters of polyplexes were measured by dynamic light
scattering using a Zetasizer 3000 (Malvern Instruments,
Malvern,UK)equippedwitha50mWinternallaser.Themeas-
urements were performed in triplicate at 25 C in 7.5 mM
HEPES–NaOH, pH 7.5 at the scattering angle 90 degrees and
analysed assuming a monomodal distribution model.
The ability of reducing conditions to destabilize RPC/
DNA polyplexes was examined by incubating polyplexes
with 25 mM DTT at 37 C for 1 h and NaCl added at varying
concentrations (0–1 M). The samples were then loaded on to a
1% agarose gel containing 0.5 mg/ml EtBr and run for 1 h at
120 V in 0.5· TBE buffer. A Typhoon gel scanner set at 533/
610 nm wavelengths and 550 V was used to scan the gel and
the quantity of DNA in particular bands analysed using
ImageQuant
TM software.
Western blot analysis
Todeterminelevelsofp75
NTRinsiRNAtreatedDRGcultures,
cells were washed twice with PBS and incubated for 15 min at
37 C with 0.25% trypsin/EDTA (Invitrogen), followed by
trituration and centrifugation at 1300 r.p.m. for 5 min. The
DRG cell pellet was re-suspended in ice-cold lysis buffer
containing 20 mM Tris–HCl, pH 7.4, 1 mM EDTA, 0.5 mM
EGTA, 150 mM NaCl, 1% NP-40 (Sigma) and protease inhib-
itor cocktail (Sigma) and incubated on ice for 30 min. After a
30 min centrifugation at 13400 g at 4 C, the lysates were
normalized for protein concentration using a colorimetric
DC protein assay (Bio-Rad, Hercules, CA, USA). Homogen-
ates and cell lysates were stored at  70 C until used for
western blot analysis. Each sample (40 mg total protein)
was incubated with Laemmeli loading buffer at 90 C for 4
min and separated on a 12% SDS–polyacrylamide gel (Invit-
rogen). Proteins were transferred to PVDF membranes (Mil-
lipore UK, Gloucestershire, UK), blocked for 1 h at room
temperature in Tris-buffered saline containing 0.1% Tween-
20 and 5% non-fat milk. Membranes were blotted overnight
for the relevant antibody. For detection, an enhanced chemi-
luminescence (ECL) system (Amersham, Buckinghamshire,
UK) and HRP-conjugated secondary antibody (1:1000; Amer-
sham) was used. Each blot was stripped and re-probed with
relevant antibodies thereafter.
Transfection studies
Polyplexes were added directly to a 48-well plate (13.5 ml per
well) containing 2–5 · 10
4 cells per well in 125 mlo fD M E M
or RPMI without FCS or containing 2–10% FCS as indicated
(cells were plated at least 24 h before transfection). Trans-
fection studies with HIS RPCs were performed both in the
presence and absence of 100 mM chloroquine. After 4 h, the
mixture containing polyplexes was discarded and replaced
with 200 ml per well of fresh media containing 10% FCS.
Cells were cultured for 24 h prior to analysis of reporter
gene expression. In some experiments, free polycations
were added to cells prior to addition of the polyplexes. To
determine the effect of altering intracellular reducing envir-
onment on transfection properties of HIS RPC/DNA poly-
plexes, cells were incubated either in the presence of
5–10 mM glutathione–monoethyl ester (GSH–MEE) for 3 h
or 20–500 mM DL-buthionine sulfoxamine (BSO) for 24 h
prior to transfection. Intracellular levels of glutathione were
determined using the method of Sebastia et al. (22). Brieﬂy,
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total volume of 100 ml of culture media and returned to the
incubator for 30 min. Fluorescence was measured on a Victor
2
plate reader (Wallac) at 360 nm excitation and 460 nm
emission wavelengths and background values subtracted.
In some experiments, DRG cultures were transfected with
siRNA using Oligofectamine reagent (Invitrogen) in 4-well
tissue culture plates (Nunc). Brieﬂy, 0.84 mg siRNA was
mixed in 50 ml Opti-MEM (Invitrogen), and 3 ml Oligofec-
tamine added. Lipoplexes were allowed to form at room tem-
perature for 30 min and then added to cells. After 5 h of
transfection, supplemented Neurobasal-A was added and
incubated for a further 72 h prior to cell lysis for analysis
by western blotting. Cell survival was determined using the
MTS assay (Promega) after exposure to free polycations or
polyplexes and normalized to values obtained in their absence
as previously described (13).
Assay of reporter genes
Luciferase expression following transfection was measured by
a luminescence assay usingcell lysates. The culture media was
discarded and cell lysates harvested after incubation of cells
for 30 min at 4 C in 100 mlo f1 · lysis reagent buffer (Pro-
mega). The lysate was gently vortexed and 20 ml was diluted
into100 mlof luciferase reaction buffer(20 mM glycylglycine,
1 mM MgCl2, 0.1 mM EDTA, 3.3 mM DTT, 0.5 mM ATP and
0.27 mM coenzyme A lithium salt). The luminescence was
integrated over 10 s on a Lumat LB9507 (Berthold Instru-
ments, UK) and the results expressed as relative light units
(RLU) per mg of cell protein, determined using the Advanced
Protein Assay (Totam Biologicals, Northampton, UK). Ana-
lysis of GFP expression was carried out on a Coulter Epics XL
ﬂow cytometer. Cells were trypsinized at appropriate times
after transfection, washed with PBS and then ﬁxed in 2%
paraformaldehyde. GFP was excited using the 488 nm line
of an Argon laser and emitted light collected at 520 nm (green
ﬂuorescence) and 575 nm (red ﬂuorescence) to enable cor-
rection for autoﬂuorescence by diagonal gating. Background
ﬂuorescence and autoﬂuorescence were determined using
mock-treated cells. Cellular debris showing reduced side-
and forward-scatter was excluded from analysis. The software
programme WinMDI was used to analyse data and expressed
as the percentage of GFP-positive cells or mean ﬂuorescence
per cell (MnX). Analysis of cells expressing GFP was per-
formed on an inverted Zeiss axiovert 100 microscope (Zeiss,
Germany) and images recorded on a SPOT camera using
SPOT imaging software v2.0 (Diagnostic Instruments Inc).
Analysis of GSH levels by multiphoton fluorescence
microscopy
Cells were plated into 8 well Permanox chamber slides at a
density of 2.5 · 10
4 cells per well and maintained in normal
growth media. After 24 h, cells were washed with PBS and
200 ml of phenol-red free media added containing 40 mM
mBCl prior to incubation of cells for 60 min at 37 C. Cells
were then washed three times with phenol-red free media prior
to analysis. Images of cells were acquired using a Bio-Rad
multiphoton ﬂuorescence microscope (MPM) based at the
Department of Engineering Science, University of Oxford,
UK. Relative GSH levels of individual cells were obtained
bylinear proﬁling of mBCl ﬂuorescence from images captured
by the MPM using the software programme Image J (National
Institutes of Health). Background ﬂuorescence was subtracted
from the mean value.
RESULTS
Preparation of histidine-rich RPCs
Two histidine-rich RPCs (HIS3 RPC and HIS6 RPC) were
prepared by oxidative polycondensation of the peptides
Cys-His3-Lys3-His3-Cys and Cys-His6-Lys3-His6-Cys using
the method previously described by Oupicky et al. (20). GPC
analysis showed that a 48 h incubation period was sufﬁcient to
produce high mwt RPCs with mwts of 113 kDa for HIS6 RPC
(Figure 1A) and 59 kDa for HIS3 RPC (data not shown). The
peptide Cys-Lys10-Cys was also used to prepare a lysine-based
RPC of mwt 65 kDa (RPC65) as a control polycation in this
study. Details of RPC sequences used in this study are given in
Table 1. Preliminary characterization by NMR to monitor
changes in the chemical shift of H5 and H6 protons demon-
strated that both the HIS6 RPC (Figure 1B) and HIS3 RPC
(data not shown) had a buffering capacity with a pKa in the
region of 5–6 corresponding to the pKa of the imidazole group.
Triggered activation of histidine-rich RPC/DNA
polyplexes
We next investigated the ability of histidine-rich RPCs to form
polyplexes with DNA and their stability in reducing condi-
tions. In the presence of the intercalating dye, ethidium brom-
ide ﬂuorescence was strongly quenched by addition of HIS6
RPCorHIS3RPCtoDNAat(w/w)ratios 4and7,respectively
(Figure 1C) indicating efﬁcient polyplex formation. Similar
trends of complexation were observed using the agarose gel
retardation assay, for instance, DNA was partially retained in
the wells by HIS6 RPC at (w/w) ratio of 2 and completely
retained at (w/w) ratios of 4 and above (Figure 1D). To deter-
mine the ability of polyplexes to be activated by reduction
HIS6 RPC/DNA at (w/w) ratio of 4was reduced with DTT and
the amount of free DNA assessed by gel electrophoresis in the
presence of salt. Figure 2 shows that a relatively low percent-
age of DNA (<13.4%) was retained in the wells by HIS6 RPC
in non-reducing conditions even in the presence of 1 M salt.
Reduction of HIS6 RPC by DTT, however, led to a signiﬁcant
increase in the amount of DNA released. Quantiﬁcation
of DNA showed that 71.9% of DNA was released in the
absence of salt and that >95% of the DNA was released
when the salt concentration was increased to 0.5 M or greater
(Figure 2).
Chloroquine-independent transfection using
histidine-rich RPCs
Having established the ability of histidine-rich RPC/DNA
polyplexes to be destabilized by reduction, we next evaluated
their transfection activity compared to PEI/DNA polyplexes,
a gold standard non-viral vector, using luciferase as a reporter
gene. For these experiments PEI/DNA polyplexes were
formed at N:P ratio of 10, which we (data not shown) and
others (23,24) have shown mediates efﬁcient gene transfer.
Initial transfections showed that HIS3 RPC/DNA polyplexes
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15- to 440-fold lower than those achieved with PEI/DNA
(Figure 3A). Chloroquine enhanced the transfection activity
of HIS3 RPC/DNA polyplexes producing a 3.2- to 12.7-fold
increase in reporter gene expression. By comparison, higher
luciferase reporter gene activity was observed using HIS6
RPC/DNA polyplexes at (w/w) ratio >24 at levels equivalent
to PEI/DNA (Figure 3B). Furthermore, the addition of chlor-
oquine prior to transfection with HIS6 RPC/DNA polyplexes
at (w/w) ratios >24 did not enhance reporter gene expression.
Fluorescence-activated cell sorting (FACS) analysis was
used to investigate the transfection properties of HIS RPC
in more detail and showed that a signiﬁcantly higher percent-
age of PC-3 cells were transfected by HIS6 RPC/DNA poly-
plexes (57.3 – 3.6%) at (w/w) ratio of 40 than PEI/DNA
(46.6 – 1.0%) (Figure 4A). By comparison, a lower percent-
age of PC-3 cells were transfected using HIS3 RPC/
DNA (18.9 – 1.4%), HIS6 monomer/DNA (11.0 – 0.9%) or
RPC65/DNA (<2%). Fluorescence microscopy also conﬁrmed
that a higher proportion of PC-3 cells were transfected by the
GFP expression plasmid using HIS6 RPC at (w/w) ratio of
40 compared to PEI (Figure 4B). We next compared the trans-
fection activity of HIS6 RPC, HIS3 RPC and PEI in a range of
different cell types. Figure 4C shows that in 7 out of 10 cell
Figure 1. Characterization of HIS RPCs and polyplex formation. (A) Mwt growth of oxidative polymerization of HIS6 RPC in DMSO over time. Dialysis of HIS
RPCswasperformedinCentriconfilters(10000mwtcutoff)withafinalvolumeof400–500ml.(B)pHtitrationcurvesofhistidineresiduesofHIS6RPCmeasured
by NMR spectroscopy. The pH titration was achieved using 10 mM HIS6 RPC dissolved in deuterated water and basified using deuterated sodium hydroxide. The
chemicalshiftfortheH5andH6protonsintheimidazoleringwereplotted(relativepositionsofH5andH6protonsareshownininset).(C)EtBrexclusionassaywas
performedaspreviouslydescribed(21)withHIS6RPC(filledsquares)andHIS3RPC(filleddiamonds).ResultsareshownasmeanandSDvaluesfromatleastthree
samples.(D)AgarosegelelectrophoresisofpCMVLuc1complexedwithHIS6RPCattheindicated(w/w)ratio.Thecontrollane(-)containsDNAalone.Therelative
locations of wells and free DNA are indicated.
Table 1. Reducible polycations used in study
Polycation Sequence Mwt
(kDa)
a
No. of monomers
per RPC
b
HIS3 RPC [Cys-His3-Lys3-His3-Cys]n 59 41
HIS6 RPC [Cys-His6-Lys3-His6-Cys]n 113 50
RPC65 [Cys-Lys10-Cys]n 65 43
HIS3 monomer Cys-His3-Lys3-His3-Cys 1.4 —
c
HIS6 monomer Cys-His6-Lys3-His6-Cys 2.2 —
c
aThe polydispersity index of RPCs was  2.
bTheapproximatenumberofmonomersperRPCisshown.Themeannumberof
monomers incorporated for all RPCs used in study was 44.7 – 4.7.
cNot applicable.
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of gene transfer compared to PEI achieving up to a 5-fold
greater number of GFP-positive cells. Similar levels of gene
transfer were observed using HIS6 RPC and PEI in A549 and
MC7 cells, and PEI mediated higher levels of GFP-positive
cells than HIS6 RPC only in liver carcinoma Alexander cells.
These results demonstrate that in many cell types HIS6
RPC possesses superior transfection capabilities than HIS3
RPC and PEI.
Delivery of mRNA and siRNA using HIS6 RPC
Efﬁcient non-viral vectors are also needed to deliver RNA
molecules for a wide range of therapeutic applications (25).
mRNA and siRNA are active within the cytoplasm and there-
fore bypass the requirement for nuclear delivery. However,
studies so far have demonstrated that unmodiﬁed PLL and
PEI-based vectors are generally too stable to release mRNA
molecules to enable efﬁcient translation to occur (26). We
therefore investigated whether histidine-rich RPCs can be
used to deliver RNA molecules such as mRNA and siRNA.
Figure 5A shows that HIS6 RPC mediated high levels of
transfection with mRNA encoding GFP in PC-3 cells. Increas-
ing the amount of HIS6 RPC used gave a greater percentage of
GFP-positive cells with highest levels of transfection achieved
using a (w/w) ratio of 24 (91.6 – 0.76%) or 40 (96.7 – 0.4%).
In contrast, GFP mRNA delivered by PEI at N:P 10 produced
only 32.9 – 2.4% GFP-positive PC-3 cells. Fluorescence
microscopy also conﬁrmed high levels of GFP mRNA trans-
fection using HIS6 RPC compared to PEI (Figure 5B).
Recent results from our group and others have implicated
the low-afﬁnity neurotrophin receptor p75
NTR as a key regu-
lator of CNS axonal growth (27,28) involved in growth cone
collapse following CNS injury (29). A potential therapeutic
strategy to promote axon regeneration is therefore to down-
regulate levels of p75
NTR (30,31). We therefore investigated
whether histidine-rich RPCs can be used to deliver siRNA
targeted against p75
NTR in primary cultures of adult rat
DRG neurons. Results from western blotting indicated virtu-
ally complete knockdown in the level of p75
NTR following
delivery of siRNA (Seq2) targeted to the mRNA of this recep-
tor using HIS6 RPC (Figure 5C), whereas there was no
decrease in p75
NTR using a scrambled version of the siRNA
(Scr2). This level of knockdown in the level of p75
NTR was
equivalent to using Oligofectamine. By comparison, PEI and
HIS3 RPC were less effective at delivering the Seq2 siRNA
Figure2.ReductiondestabilizesHIS6RPC/DNApolyplexes.TodeterminetheabilityofpolyplexestobeactivatedbyreductionHIS6RPC/DNApolyplexesformed
at (w/w) ratio of 4 were incubated with 25 mM DTT for 1 h. NaCl was added at a range of concentrations (0–1.0 M) and the amount of free DNA assessed by gel
electrophoresis. ImageQuant
TM software was used to quantify the amount of DNA released (Rel. = relaxed DNA; S.C. = supercoiled DNA).
Figure 3. Histidine-rich RPCs facilitate chloroquine-independent gene trans-
fer.PC-3cellsweretransfectedwith0.5mgpCMVLuccondensedbyeither(A)
HIS 3 RPC or (B) HIS6 RPC at the indicated (w/w) ratio. For control transfec-
tions25kDaPEI/DNApolyplexeswereformedatN:P10.Cellswereincubated
with polyplexes for 4 h in the absence (white bars)or presence(dark gray bars)
of 100 mM chloroquine and the media was discarded and replaced with fresh
media containing 10% FCS. Luciferase activity was measured after 24 h.
Results are shown as mean and SD values from at least three samples.
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of p75
NTR.
A recent study demonstrated efﬁcient siRNA delivery using
linear PEI, also known as JetPEI, in a subcutaneous mouse
tumour model (32). We therefore directly compared the ability
of HIS6 RPC and JetPEI to mediate down-regulation of GFP
expression following co-transfection of PC-3 cells with the
GFP reporter plasmid, pEGFPN1 and GFP-22 siRNA.
Figure 5D shows that at a concentration of 5 nM GFP-22
siRNA, there was >80% reduction in the mean ﬂuorescence
per cell (MnX) mediated by HIS6 RPC polyplexes formed at a
(w/w) ratio of 24. By comparison, higher concentrations
of GFP-22 siRNA (>50 nM) were required to mediate similar
levels of knockdown with JetPEI at either N:P 5 or 10 indic-
ating that silencing of GFP ﬂuorescence was less efﬁcient
using this cationic polymer as the delivery vector (Figure 5D).
At a concentration of 50 nM GFP siRNA, for example, there
was a 90% reduction in the MnX usingHIS6RPC comparedto
A
Figure4.Enhancedfrequencyofgenetransferwithhistidine-richRPCs.(A)PC-3cellsweretransfectedwith0.5mgpEGFPN1condensedbyeitherHIS3RPC,HIS6
RPC, HIS6 monomer or RPC65 at the indicated (w/w) ratio, and by 25 kDa PEI at N:P 10 (P = 0.0005). (B) Fluorescent images of PC-3 cells expressing GFP
followingtransfectionwith(i)nothingor0.5mgpEGFPN1condensedwith(ii)25kDaPEIatN:P10or(iii)HIS6RPCat(w/w)ratioof40.Phase-contrastimagesof
transfectedPC-3cellsareshowninthecorrespondingright-handcolumn.(C)Arangeofcelltypesweretransfectedasindicatedwith0.5mgpEGFPN1condensedby
25kDaPEI atN:P10(whitebars),HIS6RPC at(w/w)ratioof40(lightgreybars)orHIS3RPC at(w/w)ratioof66(darkgreybars).GFPexpressionwasmeasured
after 24 h by flow cytometry analysis. Results are shown as mean and SD values from at least three samples. Significant differences between HIS6 RPC/DNA and
25 kDa PEI/DNA transfected cells are indicated (***, P < 0.0001; **, P < 0.001; *, P < 0.01).
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strate that histidine-rich RPCs can efﬁciently deliver siRNA
molecules to mediate gene silencing atlevels similar or greater
than using commercially available transfection reagents.
Effect of salt-induced aggregation of particles on
transfection activity
The inability of chloroquine to enhance reporter gene expres-
sion using HIS6 RPC indicated that intracellular delivery of
DNA to the cytoplasm had been signiﬁcantly improved com-
pared to PLL/DNA. However, previous studies have shown
that particle size (33), cellular toxicity (8), the intracellular
reducing environment (13) or the presence of free polycation
(34) can all inﬂuence the transfection properties of polyca-
tions. We therefore investigated whether any of these factors
might contribute to the high transfection efﬁciency of
histidine-rich RPCs. First, photon correlation spectroscopy
showed that discrete particles with diameters in the range
of 36–78 nm were formed between HIS3 RPC, HIS6 RPC,
HIS3 monomer, HIS6 monomer or RPC65 with DNA
(Figure 6A and Supplementary Figure 1). The addition of
salt to histidine-rich RPC/DNA polyplexes resulted in
rapid aggregation of particles with diameters of 1273.9 nm
A B
D C
Figure5.Histidine-richRPCsmediateefficientdeliveryofmRNAandsiRNA.(A)PC-3cellsweretransfectedwith0.5mgcap-GFP-A64mRNAcondensedeitherby
PEIatN:P10(blackbar)orHIS6RPCattheindicated(w/w)ratio(darkgreybars).(B)FluorescentimagesofPC-3cellsexpressingGFPfollowingtransfectionwith
0.5mgcap-GFP-A64mRNAcondensedwith(i)25kDaPEIatN:P10or(ii)HIS6RPCat(w/w)ratioof40.Phase-contrastimagesoftransfectedPC-3cellsareshown
in the corresponding right-hand column. (C) Western blot analysis of p75
NTR (upper panel) and b-actin (lower panel) using DRG culture lysates following
transfectionwithsiRNAdirectedagainstp75
NTR(Seq2)orascrambledsequence(Scr2)andcondensedeitherby25kDaPEIatN:P10,HIS3RPCat(w/w)ratioof66,
HIS6RPCat(w/w)ratioof40orOligofectamineat(w/w)ratioof3.5asindicated.Therelative%knockdownsinp75
NTRlevelsareshowninthebargraphontheright-
handside.(D)PC-3cellswereco-transfectedwith0.5mgpEGFPN1andGFP-22siRNAattheindicateddosecondensedeitherbyJetPEIatN:P5(squares),JetPEIat
N:P10(triangles)orHIS6RPCat(w/w)ratioof24(diamonds).Inpanels(A)and(D),flowcytometryanalysiswasusedtodetermine%GFPpositivecellsandmean
fluorescence per cell (MnX) after 24 h. Results are shown as mean and SD values from at least three samples.
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ratios of 4 and 7, respectively (Figure 6A). However, HIS6
RPC/DNA polyplexes at higher (w/w) ratios >8 were gener-
ally stable in salt with average diameters between 223.0 – 1.2
and 267.3 – 4.7 nm (Figure 6A). Similarly, polyplexes formed
with the lysine-based RPC65 were also relatively stable to salt-
induced aggregation, even at low (w/w) ratios, with diameters
of  200 nm (Supplementary Figure 1). In contrast, polyplexes
formed with low mwt HIS6 monomer or HIS3 monomer
aggregated rapidly in salt with diameters >1600 nm when
formed at (w/w) ratios of 10–60 (Supplementary Figure 1).
Histidine-rich RPC/DNA polyplexes were then incubated
in salt for 30 min prior to transfection to determine whether
salt-induced aggregation directly inﬂuenced their transfec-
tion capability. A 54-fold (HIS6 RPC) and 300-fold (HIS3
RPC) increase in gene expression was observed using salt-
aggregated polyplexes at (w/w) ratios of 4 and 7, respectively.
In contrast, the addition of salt to histidine-rich RPC/DNA
polyplexes at higher (w/w) ratios of 24 and 40 did not signi-
ﬁcantly alter the level of reporter gene expression (Figure 6B).
These results indicate that preincubation of histidine-rich
RPC/DNA polyplexes at low (w/w) ratios in salt is a useful
strategy to enhance gene transfer. However, the inability of
salt to enhance transfection of HIS6 RPC/DNA polyplexes at
higher (w/w) ratios indicated that salt-induced aggregation
was not the mechanism responsible for mediating efﬁcient
gene transfer with this vector.
Cellular toxicity of PEI and histidine-rich RPCs
Cellular toxicity is often associated with efﬁcient transfection
of cells usingnon-viral vectors such as 25 kDa PEI (35), which
is likely to be due to the membrane damaging effects of
polycations (36). We therefore evaluated the toxicity of
histidine-rich RPC/DNA polyplexes at high (w/w) ratios
where there is likely to be a large excess of free polycation.
Results using the MTS viability assay demonstrated negligible
cellular toxicity with either HIS3 RPC/DNA or HIS6 RPC/
DNA at (w/w) ratio of 40 (Figure 7A). No signiﬁcant toxicity
was also detected with PEI/DNA at N:P 10 using the MTS
assay, although a signiﬁcant proportion of cells had a rounded
morphology indicating a loss of adherence (Figure 4B).
Signiﬁcant toxicity was however observed using polyplexes
based on PLL54 or PLL85 at the same (w/w) ratio with an 88%
reduction in cell viability. We next evaluated the toxicity of
free polycations using PC-3 cells and showed that increasing
the dose of PEI from 0.2 to 3 mg per 5 · 10
4 cells resulted in a
92.7% reduction in cell viability. In contrast, there was no
signiﬁcant decrease in viability of PC-3 cells even when a
4-fold higher dose of 12 mg per 5 · 10
4 cells of HIS6 RPC
wasused(Figure7B).These resultsdemonstrate thathistidine-
rich RPCs have negligible toxicity and are signiﬁcantly less
toxic than free PEI.
Effect of intracellular GSH levels on transfection
activity
We next investigated whether the transfection ability of HIS6
RPC/DNA polyplexes was inﬂuenced by the intracellular
reducing environment. A ﬂuorescence assay based on the
dye mBCl was used to determine intracellular glutathione
content (22). Using this assay, we established that cells
preincubated for 3 h in the presence of GSH–MEE, a cell
permeable form of GSH, contained a 2- to 3-fold higher
amount of GSH. Also, preincubation of cells for 24 h in the
presence of DL-BSO, an agent which depletes glutathione by
inhibiting itssynthesis, resulted ina 50–80% reduction inGSH
depending on the dose used (Figure 8A).
Up to a 210-fold decrease in gene expression was observed
when PC-3 cells were preincubated in 10 mM GSH–MEE and
Figure 6. Effect of salt-induced aggregation of particles on transfection activ-
ity. (A) Photon correlation spectroscopy was used to assess changes in the
diameter of polyplexes formed between DNA condensed with either HIS3
RPC or HIS6 RPC at the indicated (w/w) ratio in the absence (white bars)
or presence (dark grey bars) of 150 mM NaCl for 2.5 h. (B) PC-3 cells were
transfected with 0.5 mg pCMVLuc1 condensed by either PEI at N:P 10 (black
bar), HIS3 RPC or HIS6 RPC at the indicated (w/w) ratio. Polyplexes were
incubated in the absence (white bars) or presence of 150 mM NaCl for 30 min
(dark grey bars) prior to addition to cells. Luciferase activity was measured
after 24 h. Results are shown as mean and SD values from at least three
measurements.
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contrast, there was only a 3.1-fold decrease in gene expression
following transfection ofcells withPEI/DNAafter exposure to
10 mM GSH–MEE. The most signiﬁcant change in gene
expression in BSO-treated PC-3 cells was a modest 3.9-fold
decrease in luciferase reporter gene expression following
transfection with HIS6 RPC/DNA polyplexes. No signiﬁcant
changes ingene expressionwereobservedby transfection with
PEI/DNA or HIS6 monomer/DNA polyplexes following treat-
ment of PC-3 cells with BSO (Supplementary Figure 2).
The relative intracellular levels of GSH in a range of cell
types following treatment with mBCl were then studied by
multiphoton ﬂuorescence microscopic analysis (Figure 8C and
Supplementary Figures 3 and 4). In most cell types, such as
PNT2, PNT1a, COS7, HepG2, PC-3 and Skov3, small punct-
ate spherical bodies were observed that were present through-
out the cell. However in others, such as Alexander cells, these
punctate bodies were not as apparent (Figure 8C and Supple-
mentary Figure 3). Previous work has indicated that these
punctate spherical bodies may correspond to mitochondria,
which contain high intracellular stores of cellular sulfhydryls
(37). Linear proﬁling of mBCl ﬂuorescence in several cell
types demonstrated heterogeneity in GSH levels both in indi-
vidual cells and between different cell types. Alexander cells,
for example, had one of the highest GSH contents with a low
degree of heterogeneity, whereas PNT2 cells had the lowest
GSH content (Figure 8D).
Altogether, these results indicated that there was sufﬁcient
reducing capacity within cells to activate HIS RPC-based vec-
tors as BSO-treatment resulted in only a modest fall in trans-
fection activity. Furthermore, high levels of gene transfer were
still observed in cells, such as PNT2, that had one of the lowest
GSH contents (Figure 8D).Unexpectedly, increasing the intra-
cellular GSH with GSH–MEE signiﬁcantly diminished trans-
fection with HIS6 RPC/DNA polyplexes, which is in contrast
to a previous study using the RPC-based vector RPC187/
DOTAP (13). The transfection activity of histidine-rich
RPCs may therefore depend on the rate of cleavage of the
polycation as this will most likely be accelerated in cells with
elevated intracellular GSH.
Free HIS6 RPC enhances PLL-mediated gene transfer
In the present study, highest levels of gene expression were
observed using polyplexes at higher (w/w) ratios where there
is likely to be free polycation in solution. To determine
whether free HIS6 RPC can directly inﬂuence gene transfer
PC-3 cells were transfected in the absence or presence of
histidine-rich polycations with non-viral vectors such as
PLL/DNA and RPC65/DNA that are known to mediate only
low levels of gene transfer. FACS analysis showed that addi-
tion of free HIS6 RPC to PC-3 cells prior to transfection with
RPC65/DNA polyplexes resulted in a 22.4-fold increase in
GFP-positive cells from 2.24 – 0.3% to 50.2 – 1.3%
(Figure 9A). Similarly, a 2.5-fold increase in GFP-positive
cells was observed from 9.7 – 0.2% to 30.5 – 2.3% when free
HIS6 RPC was added prior to transfection with PLL/DNA
polyplexes. In contrast, there was no signiﬁcant increase in
%GFP-positive cells by addition of the HIS6 monomer to cells
prior to transfection with either RPC65/DNA or PLL/DNA.
We next incubated PC-3 cells in the presence of HIS6 RPC
for varying durations prior to addition of PLL/DNA poly-
plexes. The simultaneous addition of free HIS6 RPC with
PLL/DNA resulted in a 21.5-fold increase in gene expression
using the LUC reporter gene (Figure 9B). After a 1 h prein-
cubationwith the HIS6RPC, there was still an improvement in
gene expression but this was decreased to 5.9-fold. However,
after a 2 or 4 h preincubation with HIS6 RPC, there was no
signiﬁcant enhancement in reporter gene expression. These
results demonstrate that the presence of free HIS6 RPC can
inﬂuence the transfection activity of gene therapy vectors,
especially polyplexes based on PLL residues that are
known to be relatively inefﬁcient at mediating escape from
endocytic vesicles.
Figure 7. CellulartoxicityofPEIandhistidine-richRPCs.(A)PC-3cellswere
transfected with 0.5 mg of pCMVLuc1 condensed either by 25 kDa PEI at N:P
10orHIS6RPC,HIS3RPC,RPC65,PLL54andPLL85at(w/w)ratioof40.The
cellswereincubatedwithpolyplexesfor4hinserum-freemediaandthemedia
discarded and replaced with fresh media containing 10% FCS. The MTS assay
was used to assess the viability of transfected PC-3 cells after 24 h. (B) PC-3
cellswereincubatedinthepresenceof25kDaPEI(darkgreybars)orHIS6RPC
(light grey bars) at the indicated dose for 4 h in serum-free media. The media
wasdiscardedandreplacedwithfreshmediacontaining10%FCSandtheMTS
assayusedtoassesscellularviabilityafter24h.Resultsareshownasmeanand
SD values from at least three samples.
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Progress in the ﬁeld of gene therapy is hindered by the lack
of suitable delivery vectors. Synthetic vectors based on
polycations are promising vectors for gene delivery as they
are relatively safe and can be readily modiﬁed by the
incorporation of ligands for targeting to speciﬁc cell types
(38,39). However, the levels of gene expression mediated
by synthetic vectors are typically low compared to viral
Figure 8. EffectofintracellularGSHlevelsontransfectionactivity.(A)PC-3cellswereincubatedinthepresenceofGSH–MEEfor3h(blackbars)orBSOfor24h
(darkgreybars)attheindicatedconcentrationsandGSHlevelsdeterminedasdescribedbySebastiaetal.(22).Forcontrolexperiments,cellswereincubatedontheir
own(whitebars)orinthepresenceofHIS6RPC(lightgreybar).(B)PC-3cellswereincubatedfor3hinserum-freemediacontaining0mM(whitebars),5mM(light
grey bars) or 10 mM GSH–MEE (dark grey bars) prior to transfection with 0.5 mg pCMV-Luc1 condensed with either 25 kDa PEI at N:P 10 or HIS6 RPC at the
indicated(w/w)ratio.Luciferaseactivitywasmeasuredafter24h.ResultsareshownasmeanandSDvaluesfromatleastthreesamples.(C)Microscopiccomparison
ofGSHdistributioninisolated(i)PNT2,(ii)COS7,(iii)PNT1aand(iv)AlexandercellsbasedonmBClfluorescence.(D)RelativefluorescenceofmBCl-treatedcells
obtainedbylinearprofilingfromatleasttenstacksintheindicatedcelltype.Theemptytrianglerepresentsthemeanfluorescence,whereasverticalbarsrepresentthe
maximum and minimum levels of fluorescence. Background fluorescence was subtracted from the mean value.
PAGE 11 OF 16 Nucleic Acids Research, 2005, Vol. 33, No. 9 e86vectors. In addition, the type and molecular weight of poly-
cation used to deliver a particular type of nucleic acid has to
be carefully selected to give optimal transfection levels. For
instance, we recently showed that polyplexes based on low
mwt peptides, such as 2 kDa PEI, were signiﬁcantly more
efﬁcient at delivering mRNA than 25 kDa PEI, which was
presumably due to fewer electrostatic interactions enabling
greater access of mRNA to the translational machinery
(26). In this study, we attempted to produce a more versatile
polycation-based vector by evaluating the properties of redu-
cible polycations consisting of histidine and lysine residues.
Transfection experiments showed efﬁcient gene transfer in a
range of cell types achieving up to nearly a 5-fold increase in
the percentage of transfected cells compared to PEI. In con-
trast to PEI, histidine-rich RPCs also mediated efﬁcient trans-
fer of a broad range of nucleic acid molecules including
mRNA encoding for GFP in PC-3 cells and a 21mer siRNA
directed against the low afﬁnity neurotrophin receptor p75
NTR
in primary cultures of post-mitotic DRG neurons.
Uptake of polyplexes into cells typically occurs by endo-
cytosis where polyplexes are internalized into endocytic ves-
icles and follow the lysosomal trafﬁcking pathway eventually
leading to degradation of the polymer or DNA, or both, by the
acidic pH and by various lysosomal enzymes. The inability of
polyplexes to avoid this fate is a major barrier to efﬁcient
transfection following internalization by endocytosis (10).
Chloroquine is widely used to enhance polyplex-mediated
gene transfer in vitro by favouring the survival of polyplexes
in endocytic vesicles and promoting their release into the
cytoplasm (10,40). The precise role of chloroquine on gene
transfer is still not fully understood, although recent data from
ﬂow cytometric analysis of pH-sensitive ﬂuorophores conjug-
ated to PLL conﬁrmed that chloroquine most likely acts by
enhancing escape from endocytic vesicles, but this mechanism
does not appear to involve pH buffering (40). Previous results
from our group indicated that lysine-based RPCs were
inefﬁcient at mediating endocytic escape since chloroquine
produced a 10- to 130-fold increase in reporter gene expres-
sion (13). In this study, we demonstrated that histidine-rich
RPCs produced levels of gene expression >10
8 RLU/mg per
protein in the absence of chloroquine, which is at least 10-fold
higher than levels observed previously using lysine-based
RPCs in PC-3 cells (13). Furthermore, the inability of chlor-
oquine to enhance transfection with HIS6 RPC/DNA poly-
plexes at (w/w) ratios >24 indicated that transfer of DNA
from endocytic vesicles to the cytoplasm had been signiﬁc-
antly improved.
Histidine residues were incorporated into RPCs as the
imidazole group has a pKa  6.0 which becomes cationic in
a slightly acidic medium and may facilitate escape from endo-
cytic vesicles. Indeed, data from several groups have shown
that poly-L-histidine mediates an acid-dependent fusion and
leakage of negatively charged liposomes (41,42). In addition,
Goncalves et al. recently showed that histidylated polylysines
complexed with DNA had prolonged stability inside early
endocytic vesicles that was likely to favour DNA escape
into the cytosol (43). In this study, the content of histidine
residues appeared to be an important factor in determining the
transfection activity of RPCs. Highest transfection activity
was mediated by HIS6 RPC which contained  600 histidine
residues per polymer (70% histidine content) compared to 246
in the HIS3 RPC (55% histidine content). These results are in
contrast with those of McKenzie et al., where optimal gene
transfer was observed with disulﬁde cross-linked peptides
containing 10–30% histidine content. Increasing the histidine
content to 40–50% gave progressively lower levels of gene
transfer in HepG2 and CHO cells (44). A possible explanation
Figure 9. FreeHIS6RPCenhancesPLL54-andRPC65-mediatedgenetransfer.
(A) PC-3 cells were transfected with 0.5 mg pEFGPN1 condensed with HIS6
RPCat(w/w)ratioof40,RPC65at(w/w)ratioof2orPLL54at(w/w)ratioof2.
In these experiments, polyplexes were added to cells on their own (white bars)
or by prior additionof free HIS6 RPC (lightgrey bars)or HIS6 monomer(dark
grey bars). (B) Same as in (A) except that free HIS6 RPC was added to PC-3
cells at the indicated number of hours prior to transfection with 0.5 mg pCMV-
Luc1 condensed with PLL54 at (w/w) ratio of 2. Luciferase activity was mea-
sured after 24 h. Results are shown as mean and SD values from at least three
samples.SignificantdifferencesbetweenRPC/DNAandPLL/DNAtransfected
cells in the absence or presence of HIS6 RPC are indicated (***, P < 0.0001;
**, P = 0.0002).
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content of 40–50% produced larger particles of 205–320 nm in
diameter. In contrast, in this study the advantage of using
RPCs with 55–70% histidine content was that polyplexes
formed with DNA remained small with diameters still in
the range of 50–60 nm.
A requirement for effective gene delivery is that vectors
are relatively stable in physiological conditions. It has been
shown, for instance, that polyplexes formed with unmodiﬁed
low mwt polycations, such as 20 kDa PLL, are unsuitable for
in vivo applications as they tend to aggregate rapidly in the
presence of 150 mM salt (11). Similarly, in this study poly-
plexes formed with either HIS3 or HIS6 monomers with mwts
of 1.4–2.2 kDa formed large aggregates >1.66 mM in diameter
in salt (data not shown). An important ﬁnding in this study was
that polyplexes formed with HIS6 RPC were stabilized to
salt-induced aggregation at (w/w) ratios >8. Indeed average
diameters of HIS6 RPC-based polyplexes were  200 nm in
150 mM salt. Similarly, polyplexes formed with lysine-based
RPCs were also relatively stable in physiological salt condi-
tions with average diameters of 210 nM. The transfection
activity of lysine-based RPCs was, however, signiﬁcantly dif-
ferent to histidine-rich RPCs producing <2% GFP-positive
cells. These results therefore indicate that the enhanced trans-
fection efﬁciency mediated by histidine-rich RPCs compared
to lysine-based RPCs was likely to be due to the direct inﬂu-
ence of histidine residues and not to differences in the size or
stability of polyplexes.
Although polyplexes formed with higher mwt polymers
have improved stability in physiological conditions, data
from studies by Schaffer et al. (7) and ourselves (13) have
indicated that high mwt polymers, such as 211 kDa PLL, can
hinder vector unpacking. An important consideration in devel-
oping vectors based on high mwt histidine-rich polycations
was therefore to include cysteine residues to enable them to be
triggered by reduction to facilitate release of nucleic acids.
This was conﬁrmed by initial experiments using gel electro-
phoresis which showed that incubation of HIS6 RPC with the
reducing agent DTT facilitated release of DNA even in low
salt conditions. We studied the effect of reduction on gene
transfer in more detail by altering intracellular levels of GSH
with the reagents GSH–MEE and BSO. The most signiﬁcant
ﬁnding was a decrease of up to 210-fold in gene expression
following gene transfer with HIS6 RPC/DNA polyplexes in
GSH–MEE treated PC-3 cells. The rate of degradation of
reducible polycations will most likely be greater in cells
with elevated GSH levels, which suggests that HIS6 RPC
needs to be relatively intact to mediate efﬁcient gene transfer
and that cleavage of the polymer by reduction diminishes
transfection activity. This ﬁnding was further supported by
results from transfection of PC-3 cells using the low mwt
HIS6 RPC monomer where only low levels of gene expression
were observed. Hence, it may be possible to improve the
transfection properties of HIS RPCs by increasing their mwts.
Linear proﬁling of images of mBCl-treated cells captured
by multiphoton ﬂuorescence microscopy showed heterogen-
eity in GSH levels in a range of different cell types. There was
no direct correlation between GSH content and levels of gene
transfer mediated by HIS RPC. In particular, efﬁcient gene
transfer occurred in PNT2 cells with a low GSH content
suggesting that there was sufﬁcient reducing capacity within
cells used in this study to activate HIS RPC-based vectors.
However, based on the observations with PC-3 cells treated
with GSH–MEE, it is possible that cells with high GSH con-
tent may limit the ability of HIS RPC to mediate efﬁcient gene
transfer. Indeed, this may have contributed towards the inab-
ility of HIS RPC to mediate higher levels of gene transfer than
PEI in Alexander cells that have a high GSH content with low
heterogeneity. Although, other factors are also likely to inﬂu-
ence gene transfer with RPC-based vectors such as the level of
cytoplasmic nucleases and the rate of cell cycling of different
cell-types (45).
The ability of GSH–MEE to diminish HIS RPC-mediated
gene transfer was unexpected as previously we observed a 33-
fold increaseingene expression using the lysine-based RPC187
at a (w/w) ratio of 12.8 in combination with DOTAP in GSH–
MEE treated HeLa cells (13). However, this is likely to reﬂect
the different roles of RPCs in mediating gene transfer between
these gene delivery vectors. HIS6 RPC is most likely facilit-
ating endosomal escape of DNA, whereas the lysine-based
RPC187 condenses DNA but the DOTAP component is res-
ponsible for mediating the escape from endosomes. Hence,
the improvement in transfection observed previously with
RPC187/DOTAP in cells with elevated GSH levels is likely
to be due to improved DNA release from the polycation (13).
A schematic detailing the proposed mechanism for HIS RPC-
mediated delivery of nucleic acids is outlined in Figure 10.
Recently, the usefulness of delivering RNA has been gain-
ing greater interest and many groups are now focused on
improving the stability and delivery of RNA molecules
(25). One reason for this has been the recent emergence of
small interfering RNA (siRNA) to trigger RNA interference
with many potential therapeutic applications (46). In addition,
there is considerable interest in delivering mRNA to dendritic
cells to stimulate potent CTL responses and induce antitumour
immunity (47). In the present study, we showed that histidine-
rich RPCs were efﬁcient at delivering both mRNA and siRNA
molecules. In comparison to 25 kDa PEI, HIS6 RPC gave
a 3-fold higher percentage of GFP-positive cells with GFP
mRNA and  2-fold greater level of gene silencing of
p75
NTR in DRG cultures. Indeed, western blot analysis
showed virtually complete knockdown of p75
NTR following
delivery of siRNA by HIS6 RPC. Recent studies have also
shown efﬁcient siRNA delivery using peptide-based systems
such as JetPEI (32), Penetratin 1 (48) and a fusion peptide
domain of HIV-1 gp41 protein and the nuclear localization
sequence of SV40large Tantigen (49). However, to the best of
our knowledge this isthe ﬁrst demonstration of effective deliv-
ery of an siRNA molecule by a reducible polycation-based
system in post-mitotic cells. Furthermore, we were able to
demonstrate in co-transfection experiments the ability of
HIS RPCs to deliver GFP-22 siRNA and silence GFP expres-
sion at siRNA concentrations signiﬁcantly lower than those
required using JetPEI.
Throughout this study, the ability of histidine-rich RPCs to
deliver nucleic acids was compared with 25 kDa PEI (4),
which is one of the most widely studied polycations and is
generally regarded as a gold-standard synthetic vector. Our
results demonstrated that HIS RPCs shared several important
transfection properties similar to PEI. For instance, Ogris et al.
showed that salt-induced aggregation of 800 kDa branched
PEI/DNA polyplexes at low N:P ratios was associated with
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salt-induced aggregation of HIS RPC/DNA polyplexes at low
(w/w) ratios enhanced reporter gene expression by up to 300-
fold. Polyplexes formed at higher (w/w) ratios were, however,
relatively unaffected by the presence of salt with no signiﬁcant
changes in gene expression. Free PEI has also been shown to
enhance the transfection activity of polyplexes (34,50), espe-
cially those formed with polycations that are known to have a
poor ability to facilitate escape from endocytic vesicles. In
this study, the addition of HIS6 RPC to cells prior to trans-
fection mediated by RPC65 resulted in a 22.4-fold increase in
the percentage of GFP-positive cells. This level of enhance-
ment was, however, diminished by increasing the duration of
exposure of HIS6 RPC to cells prior to transfection, which is
likely to be associated with the rate of turnover of the polyca-
tion in cells.
Despite the high levels of gene transfer that can be achieved
with PEI both in vitro (4) and in vivo (51), there are concerns
over its use due to toxicity. For instance, PEI has been shown
to be toxic in many cell lines leading to reduced cell metabolic
activity (52) and cell adherence (53). A goal of the present
study was to develop a polycation capable of mediating
nucleic acid transfer at levels similar or greater than PEI
but without causing signiﬁcant toxicity. We were able to
demonstrate superior nucleic acid transfer capabilities of
histidine-rich RPCs compared to PEI in the majority of cell
types used and in primary cultures of post-mitotic cells. Fur-
thermore, there was negligible toxicity following incubation
of cells with HIS6 RPC compared to a 90% reduction in cell
viability when a 4-fold lower dose of free PEI was used.
Previous studies have shown that the cytotoxicity of cationic
polymers such as polylysine and poly(amidoamines) increases
with increasing mwt (54). Hence, the negligible toxicity
observed with HIS6 RPC may well reﬂect its capacity to be
cleavedbyreduction intoshorterpeptideswithalowertoxicity
proﬁle.
To date many studies have demonstrated that existing
delivery vectors can be modiﬁed or novel types of vectors
developed to overcome speciﬁc barriers to transfection. The
challenges now lie in integrating many of these different func-
tionalities into a single type of efﬁcient delivery vector. We
have shown that HIS RPCs can be developed that incorporate
multiple features to overcome several barriers to transfection,
including the ability to mediate escape from endocytic ves-
icles, efﬁcient intracellular release of nucleic acids and a low
toxicity proﬁle. We also demonstrated that HIS RPCs can
be used for efﬁcient cytoplasmic delivery of a broad range
of nucleic acids. This will enable different or a combination
of therapeutic strategies to be evaluated with a single type of
polycation-based vector.
Figure 10. Proposed mechanism for HIS RPC-mediated delivery of nucleic acids. HIS RPC/DNA polyplexes are first internalized by endocytosis (1) and mediate
escapefromendocyticvesiclesintothecytoplasm(2)thusavoidingdegradationinlysosomalcompartments(3).InthecaseofHIS3RPC-basedvectors,endosomal
escape can be triggered by the buffering agent chloroquine (4). Intracellular reduction of HIS RPC-based polyplexes enables efficient cytoplasmic release (5)
enabling transcription (6), translation (7) or RNA interference (8) to proceed depending on the nucleic acid payload.
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can be used directly for in vivogene transfer or whether further
modiﬁcations are required. In this study, transfections were
performed inthe absence of serum toavoidmaskingthe ability
of histidine residues to enhance gene transfer that may have
arisen from binding of serum proteins to polyplexes restricting
cellular uptake (9). Preliminary experiments indicate that the
transfection properties of HIS RPC polyplexes can be affected
bythe presence ofserum proteinswith a50%decreaseinGFP-
positive cells observed in 10% FCS (Supplementary Figure 5).
We also observed a similar decrease in the proportion of GFP-
positive cells in serum usingJetPEI as the transfection reagent,
which has been used successfully in vivo (32). However, in
contrast to HIS6 RPC, with JetPEI mediated gene transfer
there was no signiﬁcant reduction in the mean ﬂuorescence
levels per cell. Therefore, based on these observations it is
envisaged that hydrophilic polymers and targeting ligands
will need to be attached to HIS RPC-based polyplexes
to further improve their stability and biocompatibility for
in vivo applications. Towards this goal, we have previously
shown that lysine-based RPCs can be readily modiﬁed by
attachment of the hydrophilic polymer poly-[N-(2-hydroxy-
propyl)methacrylamide] (pHPMA) and basic ﬁbroblast
growth factor (bFGF) (20).
In conclusion, we have developed histidine-rich reducible
polycations for safe and efﬁcient intracellular delivery of
nucleic acids, such as siRNA, with the potential to be readily
modiﬁed for use in therapeutic applications. These properties
shouldhelp tofacilitate the design andconstruction ofefﬁcient
and versatile non-viral vectors for gene transfer applications.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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